YOSEPH SHAALTIEL has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in Israel. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are SHENYANG FUYANG PHARMACEUTICAL TECH CO LTD, OXTHERA INTELLECTUAL PROPERTY AB and ANGSTROM PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 14 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Enzymes | |
#5 | Microbiology | |
#6 | Analysing materials | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Yoseph Shaaltiel | 9 |
#2 | Tali Kizhner | 6 |
#3 | Avidor Shulman | 5 |
#4 | Uri Hanania | 4 |
#5 | Ilya Ruderfer | 3 |
#6 | Yaron Naos | 2 |
#7 | Alon Shtainiz | 2 |
#8 | Tami Ariel | 2 |
#9 | Yftach Shneor | 2 |
#10 | Talia Shekhter | 2 |
Publication | Filing date | Title |
---|---|---|
IL241221D0 | Use of plant cells expressing a tnfalpha polypeptide inhibitor in therapy | |
IL241151D0 | Tnf alpha inhibitor polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same | |
IL233879D0 | Drypowder formulations of dnase i | |
IL233878D0 | Inhalable liquid formulations of dnase i | |
IL229100D0 | Large scale disposable bioreactor including a plurality of gas exchange ports | |
IL201799D0 | Production of high mannose proteins in plant culture |